ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 176323 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 176323; 2) Community: the network communities that were significantly associated with the response to NSC 176323; 3) Molecule: the relationships between components within communities and NSC 176323; 4) MDR: the compounds that were significantly associated with the NSC 176323.

NSC Compound Enrichment Correlation
NSC 673787 Null 0.0137891122538509 0.2598581
NSC 674182 Null 0.0137891122538509 0.57256467
NSC 679006 2-Butenedioic acid, 2,2'-(5-methyl-2,4-dioxopyrimidine- 1,3-diyl)bis-, tetraethyl ester 0.0137891122538509 0.056692174
NSC 681632 Camptothecin Derivative 0.0137891122538509 0.78912906
NSC 721385 5-fluoro-2'-deoxyuridyl 5-nitrofuryl N-methyl-N-(4-chlorobutyl) phosphoramidate 0.0137891122538509 0.39055189
NSC 727729 1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one 0.0137891122538509 0.56639058
NSC 748382 Null 0.0137891122538509 0.072703423
NSC 759878 Irinotecan hydrochloride (USAN) 0.0137891122538509 0.80988266
NSC 100880 Camptothecin 0.013789112253851 0.88153628
NSC 117187 Indole-2,3-dione, 5,7-dichloro-, 3-[(o-nitrophenyl) hydrazone] 0.0171490505199911 0.058748296
Total:54  Current:21    [First] [Prev] [Next] [Last]